Andrea Toloba

Ms. Andrea Toloba

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2021 in Journal of Endocrinological Investigation
Verified
Journal Article
Closed access
PDF file
JOJoaquim Oristrell
Joaquim Oristrell
JOJ. C. Oliva
J. C. Oliva
Enrique CasadoEnrique Casado
Enrique Casado
ISI. Subirana
I. Subirana
DDD. Domínguez
D. Domínguez
MGMaria Grau
Maria Grau

5 May 2021 in Biomedicines
Verified
Journal Article
Open access
PDF file
JOJoaquim Oristrell
Joaquim Oristrell
JOJoan Carles Oliva
Joan Carles Oliva
ISIsaac Subirana
Isaac Subirana
Enrique CasadoEnrique Casado
Enrique Casado
DDDidier Domínguez
Didier Domínguez
MGMaria Grau
Maria Grau
Treatment with calcitriol, the hormonal form of vitamin D, has shown beneficial effects in experimental models of acute lung injury. In this study, we aimed to analyze the associations between calcitriol supplementation and the risk of SARS-CoV2 infection or COVID-19 mortality. Individuals ≥18 years old living in Catalonia and supplemented with calcitriol from April 2019 to February 2020 were compared with propensity score matched controls. Outcome variables were SARS-CoV2 infection, severe COVID-19 and COVID-19 mortality. Associations between calcitriol supplementation and outcome variables were analyzed using multivariable Cox proportional regression. A total of 8076 patients were identified as being on calcitriol treatment. Advanced chronic kidney disease and hypoparathyroidism were the most frequent reasons for calcitriol supplementation in our population. Calcitriol use was associated with reduced risk of SARS-CoV2 infection (HR 0.78 [CI 95% 0.64–0.94], p = 0.010), reduced risk of severe COVID-19 and reduced COVID-19 mortality (HR 0.57 (CI 95% 0.41–0.80), p = 0.001) in patients with advanced chronic kidney disease. In addition, an inverse association between mean daily calcitriol dose and COVID-19 severity or mortality was observed in treated patients, independently of renal function. Our findings point out that patients with advanced chronic kidney disease could benefit from calcitriol supplementation during the COVID-19 pandemic.

Verified
Journal Article
Open access
PDF file
PLPatricio Maragaño Lizama
Patricio Maragaño Lizama
DRDiana L. Ríos
Diana L. Ríos
ICIsaac Subirana Cachinero
Isaac Subirana Cachinero
ATAndrea Toloba
Andrea Toloba
ACAnna Camps-Vilaró
Anna Camps-Vilaró
IPIvan Palomo
Ivan Palomo
The present study aimed to determine the relationship between the prevalence of cardiovascular risk factors and the number and severity of coronary artery atherosclerotic lesions obtained by coronary angiography. We reviewed and analyzed 1642 records from consecutive patients at the Catheter Laboratory of Talca Regional Hospital in Chile between March 2018 and May 2019. Patients were stratified according to the presence and severity of atherosclerotic lesions: 632 (38.5%) had no lesions or <30% stenosis and 1010 (61.5%) had at least one coronary atherosclerotic lesion with ≥30% stenosis (CALS-30). CALS-30 was more frequent in males, smokers, and patients with diabetes and/or hypertension (all p-values < 0.02). Serum potassium, glycaemia, creatinine and glomerular filtration rates were also associated with CALS-30 (all p-values < 0.01) in males. The age and the proportion of males with CALS-30 increased with the number of risk factors (p-values for trends < 0.001). Our results showed a stronger association between the accumulation of risk factors and CALS-30 in women than in men. Serum potassium levels were inversely associated with CALS-30 in men but not in women.

28 February 2023 in Revista Española de Cardiología (English Edition)
Verified
Journal Article
Closed access
HTHelena Tizón-Marcos
Helena Tizón-Marcos
ATAndrea Toloba
Andrea Toloba
ICIsaac Subirana Cachinero
Isaac Subirana Cachinero
RERoberto Elosua
Roberto Elosua
ASAlessandro Sionis
Alessandro Sionis
JMJaume Marrugat
Jaume Marrugat